Tuesday, February 18, 2025 | 10:54 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

US, UK in focus as pharma companies eye $31 billion exports in FY25

Industry also working to pump up business in Africa and Russia, regions battling geopolitical crises

drugs, medical, medicine
Premium

In 2022, the number of prescriptions filled by Americans rose to 6.7 billion, marking a 3.6 per cent increase from 2021, according to a report titled US-India Medicine Partnership: India’s Contribution to the US Healthcare System by IQVIA | File ima

Sohini Das Mumbai
As India seeks $31 billion in pharmaceutical exports in financial year 2024-25 (FY25), the United Kingdom (UK) and the United States (US) are its top targets.

India exported pharmaceutical products worth $27.9 billion in FY24, growing 9.6 per cent from the year before.

Udaya Bhaskar, director general of the Pharmaceutical Exports Promotion Council (Pharmexcil), said the group targets $1 billion in exports to the UK where demand for affordable generics is rising. “We were in the UK last month for meetings. We are also planning a road show in Belgium, the Netherlands, and the UK in November or so,” he

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in